Observational / CohorttaVNSn = 20

Neural activity changes in first-episode, drug-naive patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study

Yi S, Wang Z, Yang W, Huang C, Liu P, Chen Y, Zhang H, Zhao G, Li W, Fang J, et al.

Frontiers in Neuroscience · 2022

Key finding

In 20 first-episode, drug-naive MDD patients, 4 weeks of taVNS significantly reduced HAMD scores from 20.11 to 9.83, alongside regional homogeneity changes.

Condition
Depression
Stimulation
taVNS
Evidence tier
Observational / Cohort
Participants
20
View on DOI

Cite this study

Yi, S., Wang, Z., Yang, W., Huang, C., Liu, P., Chen, Y., Zhang, H., Zhao, G., Li, W., Fang, J., & Liu, J. (2022). Neural activity changes in first-episode, drug-naive patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.1018387

Related studies in Depression

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.